Company Profile
Reviva Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- RVPH
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.42 USD (-15.80%)
Close
Last updated: July 28, 2026
—
Market cap
Why the stock is moving
As of Jul 28, 2026, RVPH closed down 15.8% at $0.4225. No new same-company headline was identified in the current news window.
Company overview
Business overview
Reviva Pharmaceuticals is a neuroscience and inflammation company focused on small-molecule therapies for CNS and respiratory disease. Its pipeline aims at underserved conditions with clear biological logic.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Reviva sits in specialty biopharma.
Business Model Characteristics
The company depends on clinical validation, dose strategy, and the ability to build a differentiated CNS or inflammation franchise.
Position Within the Biotechnology Landscape
Reviva is a small-cap catalyst name with strong dependence on early clinical outcomes.
Future catalysts
Reviva’s catalysts are brilaroxazine and its CNS pipeline, where any data update can still move the stock sharply. The company needs a credible clinical step to keep the story alive.
Recent news
- 01
Reviva to Participate in Fireside Chat at A.G.P.’s Annual Healthcare Company Showcase
Source: Reviva Pharmaceuticals
- 02
Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
Source: Reviva Pharmaceuticals
- 03
- 04
Reviva Announces Letter to Shareholders
Source: Reviva Pharmaceuticals
- 05
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights
Source: Reviva Pharmaceuticals
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Reviva Pharmaceuticals (RVPH)?
Reviva Pharmaceuticals (RVPH) most recently closed at 0.42 USD, a -15.80% move versus the previous session.
What does Reviva Pharmaceuticals do?
Reviva Pharmaceuticals is a neuroscience and inflammation company focused on small-molecule therapies for CNS and respiratory disease. Its pipeline aims at underserved conditions with clear biological logic.
On which exchange is RVPH stock listed?
Reviva Pharmaceuticals (RVPH) is associated with NASDAQ, United States, Biopharma.
What is Reviva?
Reviva’s catalysts are brilaroxazine and its CNS pipeline, where any data update can still move the stock sharply.
Which conditions is Reviva Pharmaceuticals targeting with Reviva?
Reviva Pharmaceuticals is associated with inflammatory disease, neuroscience, respiratory disease based on its company overview and current catalyst commentary.
How does Reviva Pharmaceuticals describe recent progress with Reviva?
Reviva’s catalysts are brilaroxazine and its CNS pipeline, where any data update can still move the stock sharply.
What is Pharmaceuticals?
Reviva Pharmaceuticals is a neuroscience and inflammation company focused on small-molecule therapies for CNS and respiratory disease.
What should investors watch for with Pharmaceuticals?
Reviva’s catalysts are brilaroxazine and its CNS pipeline, where any data update can still move the stock sharply. The company needs a credible clinical step to keep the story alive.